期刊
SLEEP MEDICINE CLINICS
卷 13, 期 2, 页码 137-+出版社
ELSEVIER INC
DOI: 10.1016/j.jsmc.2018.03.002
关键词
Neurotransmitters; Neuromodulators; Glutamate; Acetylcholine; Norepinephrine; Dopamine; GABA; Adenosine
资金
- Swiss National Science Foundation [320030_163439]
- Zurich Center for Interdisciplinary Sleep Research, Clinical Research Priority Program Sleep & Health of the University of Zurich
- Zurich Center for Integrative Human Physiology
- Neuroscience Center Zurich
- Novartis Foundation for Medical-Biological Research [08C42]
- Lundbeck Foundation [R209-2015-3438]
The regulated alternations between wakefulness and sleep states reflect complex behavioral processes, orchestrated by distinct neurochemical changes in brain parenchyma. No single neurotransmitter or neuromodulator controls the sleep-wake states in isolation. Rather, fine-tuned interactions within organized neuronal circuits regulate waking and sleep states and drive their transitions. Structural or functional dysregulation and medications interfering with these ensembles can lead to sleep-wake disorders and exert wanted or unwanted pharmacologic actions on sleepwake states. Knowledge of the neurochemical bases of sleep-wake states, which are discussed in this article, provides the conceptual framework for understanding pharmacologic effects on sleep and wake.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据